nodes	percent_of_prediction	percent_of_DWPC	metapath
Dolasetron—CYP2D6—epilepsy syndrome	0.232	1	CbGaD
Dolasetron—CYP2C9—Trimethadione—epilepsy syndrome	0.0346	0.074	CbGbCtD
Dolasetron—CYP2C9—Fosphenytoin—epilepsy syndrome	0.0325	0.0696	CbGbCtD
Dolasetron—CYP2C9—Carbamazepine—epilepsy syndrome	0.0234	0.05	CbGbCtD
Dolasetron—CYP2C9—Primidone—epilepsy syndrome	0.0218	0.0467	CbGbCtD
Dolasetron—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0216	0.0463	CbGbCtD
Dolasetron—CYP2C9—Phenytoin—epilepsy syndrome	0.021	0.0449	CbGbCtD
Dolasetron—CYP3A4—Trimethadione—epilepsy syndrome	0.0201	0.0431	CbGbCtD
Dolasetron—CYP3A4—Felbamate—epilepsy syndrome	0.0201	0.0431	CbGbCtD
Dolasetron—CYP2C9—Propofol—epilepsy syndrome	0.0196	0.0418	CbGbCtD
Dolasetron—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0189	0.0405	CbGbCtD
Dolasetron—CYP2C9—Phenobarbital—epilepsy syndrome	0.0187	0.04	CbGbCtD
Dolasetron—CYP2D6—Propofol—epilepsy syndrome	0.0179	0.0383	CbGbCtD
Dolasetron—CYP2C9—Diazepam—epilepsy syndrome	0.0177	0.0379	CbGbCtD
Dolasetron—CYP3A4—Clonazepam—epilepsy syndrome	0.0171	0.0366	CbGbCtD
Dolasetron—CYP3A4—Clobazam—epilepsy syndrome	0.0164	0.0351	CbGbCtD
Dolasetron—CYP2C9—Valproic Acid—epilepsy syndrome	0.014	0.0299	CbGbCtD
Dolasetron—CYP3A4—Rufinamide—epilepsy syndrome	0.0139	0.0298	CbGbCtD
Dolasetron—CYP3A4—Carbamazepine—epilepsy syndrome	0.0136	0.0291	CbGbCtD
Dolasetron—CYP3A4—Primidone—epilepsy syndrome	0.0127	0.0272	CbGbCtD
Dolasetron—CYP3A4—Phenytoin—epilepsy syndrome	0.0122	0.0261	CbGbCtD
Dolasetron—CYP3A4—Propofol—epilepsy syndrome	0.0114	0.0243	CbGbCtD
Dolasetron—CYP3A4—Phenobarbital—epilepsy syndrome	0.0109	0.0233	CbGbCtD
Dolasetron—CYP3A4—Acetazolamide—epilepsy syndrome	0.0109	0.0233	CbGbCtD
Dolasetron—CYP3A4—Midazolam—epilepsy syndrome	0.0107	0.0229	CbGbCtD
Dolasetron—CYP3A4—Diazepam—epilepsy syndrome	0.0103	0.022	CbGbCtD
Dolasetron—CYP3A4—Zonisamide—epilepsy syndrome	0.0101	0.0215	CbGbCtD
Dolasetron—CYP3A4—Valproic Acid—epilepsy syndrome	0.00812	0.0174	CbGbCtD
Dolasetron—CYP3A4—Topiramate—epilepsy syndrome	0.00733	0.0157	CbGbCtD
Dolasetron—HTR3A—vagus nerve—epilepsy syndrome	0.00612	0.371	CbGeAlD
Dolasetron—HTR3A—ganglion—epilepsy syndrome	0.00236	0.143	CbGeAlD
Dolasetron—HTR3A—brainstem—epilepsy syndrome	0.00103	0.0622	CbGeAlD
Dolasetron—HTR3A—forebrain—epilepsy syndrome	0.00099	0.06	CbGeAlD
Dolasetron—Hyoscyamine—CHRM3—epilepsy syndrome	0.000941	0.201	CrCbGaD
Dolasetron—HTR3A—telencephalon—epilepsy syndrome	0.000911	0.0552	CbGeAlD
Dolasetron—Hyoscyamine—CHRM1—epilepsy syndrome	0.000877	0.187	CrCbGaD
Dolasetron—Atropine—CHRM3—epilepsy syndrome	0.0008	0.171	CrCbGaD
Dolasetron—Atropine—CHRM1—epilepsy syndrome	0.000746	0.159	CrCbGaD
Dolasetron—Hyoscyamine—CHRM2—epilepsy syndrome	0.000716	0.153	CrCbGaD
Dolasetron—CYP2D6—hindbrain—epilepsy syndrome	0.000658	0.0399	CbGeAlD
Dolasetron—Atropine—CHRM2—epilepsy syndrome	0.000609	0.13	CrCbGaD
Dolasetron—HTR3A—head—epilepsy syndrome	0.000567	0.0344	CbGeAlD
Dolasetron—HTR3A—nervous system—epilepsy syndrome	0.000538	0.0326	CbGeAlD
Dolasetron—HTR3A—central nervous system—epilepsy syndrome	0.000518	0.0314	CbGeAlD
Dolasetron—HTR3A—brain—epilepsy syndrome	0.000411	0.0249	CbGeAlD
Dolasetron—CYP2D6—brainstem—epilepsy syndrome	0.000377	0.0228	CbGeAlD
Dolasetron—CYP2D6—forebrain—epilepsy syndrome	0.000364	0.0221	CbGeAlD
Dolasetron—CYP2D6—telencephalon—epilepsy syndrome	0.000335	0.0203	CbGeAlD
Dolasetron—CYP2D6—head—epilepsy syndrome	0.000208	0.0126	CbGeAlD
Dolasetron—CYP3A4—nervous system—epilepsy syndrome	0.000201	0.0122	CbGeAlD
Dolasetron—CYP2D6—nervous system—epilepsy syndrome	0.000198	0.012	CbGeAlD
Dolasetron—CYP3A4—central nervous system—epilepsy syndrome	0.000193	0.0117	CbGeAlD
Dolasetron—CYP2D6—central nervous system—epilepsy syndrome	0.00019	0.0115	CbGeAlD
Dolasetron—CYP2D6—cerebellum—epilepsy syndrome	0.000186	0.0113	CbGeAlD
Dolasetron—CYP2D6—brain—epilepsy syndrome	0.000151	0.00915	CbGeAlD
Dolasetron—HTR3A—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	9.25e-05	0.00212	CbGpPWpGaD
Dolasetron—CYP3A4—Metapathway biotransformation—KCNAB2—epilepsy syndrome	9.14e-05	0.0021	CbGpPWpGaD
Dolasetron—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C19—epilepsy syndrome	8.8e-05	0.00202	CbGpPWpGaD
Dolasetron—CYP2D6—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	8.75e-05	0.00201	CbGpPWpGaD
Dolasetron—CYP2C9—Phase 1 - Functionalization of compounds—CYP2C19—epilepsy syndrome	8.72e-05	0.002	CbGpPWpGaD
Dolasetron—CYP2C9—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	8.67e-05	0.00199	CbGpPWpGaD
Dolasetron—HTR3A—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	8.6e-05	0.00198	CbGpPWpGaD
Dolasetron—HTR3A—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	7.86e-05	0.00181	CbGpPWpGaD
Dolasetron—CYP2C9—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	7.82e-05	0.0018	CbGpPWpGaD
Dolasetron—HTR3A—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	7.66e-05	0.00176	CbGpPWpGaD
Dolasetron—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—epilepsy syndrome	7.52e-05	0.00173	CbGpPWpGaD
Dolasetron—Agitation—Pregabalin—epilepsy syndrome	7.49e-05	0.000318	CcSEcCtD
Dolasetron—Headache—Levetiracetam—epilepsy syndrome	7.49e-05	0.000318	CcSEcCtD
Dolasetron—Angioedema—Pregabalin—epilepsy syndrome	7.45e-05	0.000316	CcSEcCtD
Dolasetron—Hypersensitivity—Clonazepam—epilepsy syndrome	7.45e-05	0.000316	CcSEcCtD
Dolasetron—Dizziness—Vigabatrin—epilepsy syndrome	7.44e-05	0.000316	CcSEcCtD
Dolasetron—Confusional state—Valproic Acid—epilepsy syndrome	7.42e-05	0.000315	CcSEcCtD
Dolasetron—Pruritus—Zonisamide—epilepsy syndrome	7.42e-05	0.000315	CcSEcCtD
Dolasetron—CYP2C9—Arachidonic acid metabolism—GPX1—epilepsy syndrome	7.41e-05	0.0017	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—IL1B—epilepsy syndrome	7.4e-05	0.0017	CbGpPWpGaD
Dolasetron—Hypersensitivity—Phenytoin—epilepsy syndrome	7.4e-05	0.000314	CcSEcCtD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—CASP3—epilepsy syndrome	7.38e-05	0.0017	CbGpPWpGaD
Dolasetron—Flatulence—Gabapentin—epilepsy syndrome	7.37e-05	0.000313	CcSEcCtD
Dolasetron—Oedema—Valproic Acid—epilepsy syndrome	7.36e-05	0.000312	CcSEcCtD
Dolasetron—Anaphylactic shock—Valproic Acid—epilepsy syndrome	7.36e-05	0.000312	CcSEcCtD
Dolasetron—Urticaria—Lamotrigine—epilepsy syndrome	7.36e-05	0.000312	CcSEcCtD
Dolasetron—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	7.36e-05	0.000312	CcSEcCtD
Dolasetron—Bradycardia—Topiramate—epilepsy syndrome	7.35e-05	0.000312	CcSEcCtD
Dolasetron—Malaise—Pregabalin—epilepsy syndrome	7.35e-05	0.000312	CcSEcCtD
Dolasetron—Diarrhoea—Felbamate—epilepsy syndrome	7.33e-05	0.000311	CcSEcCtD
Dolasetron—Vertigo—Pregabalin—epilepsy syndrome	7.32e-05	0.000311	CcSEcCtD
Dolasetron—Abdominal pain—Lamotrigine—epilepsy syndrome	7.32e-05	0.000311	CcSEcCtD
Dolasetron—Body temperature increased—Lamotrigine—epilepsy syndrome	7.32e-05	0.000311	CcSEcCtD
Dolasetron—Dysgeusia—Gabapentin—epilepsy syndrome	7.32e-05	0.000311	CcSEcCtD
Dolasetron—Dizziness—Diazepam—epilepsy syndrome	7.32e-05	0.000311	CcSEcCtD
Dolasetron—Syncope—Pregabalin—epilepsy syndrome	7.31e-05	0.00031	CcSEcCtD
Dolasetron—Rash—Fosphenytoin—epilepsy syndrome	7.27e-05	0.000309	CcSEcCtD
Dolasetron—Dermatitis—Fosphenytoin—epilepsy syndrome	7.27e-05	0.000309	CcSEcCtD
Dolasetron—Asthenia—Clonazepam—epilepsy syndrome	7.25e-05	0.000308	CcSEcCtD
Dolasetron—Headache—Fosphenytoin—epilepsy syndrome	7.23e-05	0.000307	CcSEcCtD
Dolasetron—Thrombocytopenia—Valproic Acid—epilepsy syndrome	7.21e-05	0.000306	CcSEcCtD
Dolasetron—Palpitations—Pregabalin—epilepsy syndrome	7.2e-05	0.000306	CcSEcCtD
Dolasetron—Asthenia—Phenytoin—epilepsy syndrome	7.2e-05	0.000306	CcSEcCtD
Dolasetron—Tachycardia—Valproic Acid—epilepsy syndrome	7.18e-05	0.000305	CcSEcCtD
Dolasetron—Diarrhoea—Zonisamide—epilepsy syndrome	7.18e-05	0.000305	CcSEcCtD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—JUN—epilepsy syndrome	7.17e-05	0.00165	CbGpPWpGaD
Dolasetron—Loss of consciousness—Pregabalin—epilepsy syndrome	7.17e-05	0.000304	CcSEcCtD
Dolasetron—Asthenia—Oxcarbazepine—epilepsy syndrome	7.16e-05	0.000304	CcSEcCtD
Dolasetron—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—epilepsy syndrome	7.16e-05	0.00164	CbGpPWpGaD
Dolasetron—Pruritus—Clonazepam—epilepsy syndrome	7.15e-05	0.000304	CcSEcCtD
Dolasetron—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—epilepsy syndrome	7.14e-05	0.00164	CbGpPWpGaD
Dolasetron—Oedema peripheral—Topiramate—epilepsy syndrome	7.12e-05	0.000302	CcSEcCtD
Dolasetron—Hyperhidrosis—Valproic Acid—epilepsy syndrome	7.11e-05	0.000302	CcSEcCtD
Dolasetron—Cough—Pregabalin—epilepsy syndrome	7.11e-05	0.000302	CcSEcCtD
Dolasetron—Pruritus—Phenytoin—epilepsy syndrome	7.1e-05	0.000302	CcSEcCtD
Dolasetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C19—epilepsy syndrome	7.1e-05	0.00163	CbGpPWpGaD
Dolasetron—Rash—Vigabatrin—epilepsy syndrome	7.09e-05	0.000301	CcSEcCtD
Dolasetron—Dizziness—Felbamate—epilepsy syndrome	7.08e-05	0.000301	CcSEcCtD
Dolasetron—Dermatitis—Vigabatrin—epilepsy syndrome	7.08e-05	0.000301	CcSEcCtD
Dolasetron—Pruritus—Oxcarbazepine—epilepsy syndrome	7.07e-05	0.0003	CcSEcCtD
Dolasetron—Convulsion—Pregabalin—epilepsy syndrome	7.06e-05	0.0003	CcSEcCtD
Dolasetron—Hypersensitivity—Carbamazepine—epilepsy syndrome	7.06e-05	0.0003	CcSEcCtD
Dolasetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—epilepsy syndrome	7.05e-05	0.00162	CbGpPWpGaD
Dolasetron—Headache—Vigabatrin—epilepsy syndrome	7.04e-05	0.000299	CcSEcCtD
Dolasetron—Hypertension—Pregabalin—epilepsy syndrome	7.04e-05	0.000299	CcSEcCtD
Dolasetron—Anorexia—Valproic Acid—epilepsy syndrome	7.02e-05	0.000298	CcSEcCtD
Dolasetron—CYP3A4—Oxidation by Cytochrome P450—CYP2C19—epilepsy syndrome	7e-05	0.00161	CbGpPWpGaD
Dolasetron—Tremor—Gabapentin—epilepsy syndrome	7e-05	0.000297	CcSEcCtD
Dolasetron—Rash—Diazepam—epilepsy syndrome	6.98e-05	0.000296	CcSEcCtD
Dolasetron—Dermatitis—Diazepam—epilepsy syndrome	6.97e-05	0.000296	CcSEcCtD
Dolasetron—Visual impairment—Topiramate—epilepsy syndrome	6.96e-05	0.000296	CcSEcCtD
Dolasetron—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—epilepsy syndrome	6.96e-05	0.0016	CbGpPWpGaD
Dolasetron—Chest pain—Pregabalin—epilepsy syndrome	6.94e-05	0.000295	CcSEcCtD
Dolasetron—Arthralgia—Pregabalin—epilepsy syndrome	6.94e-05	0.000295	CcSEcCtD
Dolasetron—Myalgia—Pregabalin—epilepsy syndrome	6.94e-05	0.000295	CcSEcCtD
Dolasetron—Ill-defined disorder—Gabapentin—epilepsy syndrome	6.94e-05	0.000294	CcSEcCtD
Dolasetron—Dizziness—Zonisamide—epilepsy syndrome	6.93e-05	0.000294	CcSEcCtD
Dolasetron—Headache—Diazepam—epilepsy syndrome	6.93e-05	0.000294	CcSEcCtD
Dolasetron—Anxiety—Pregabalin—epilepsy syndrome	6.92e-05	0.000294	CcSEcCtD
Dolasetron—Diarrhoea—Clonazepam—epilepsy syndrome	6.92e-05	0.000294	CcSEcCtD
Dolasetron—Anaemia—Gabapentin—epilepsy syndrome	6.91e-05	0.000293	CcSEcCtD
Dolasetron—Hypotension—Valproic Acid—epilepsy syndrome	6.88e-05	0.000292	CcSEcCtD
Dolasetron—Asthenia—Carbamazepine—epilepsy syndrome	6.88e-05	0.000292	CcSEcCtD
Dolasetron—Agitation—Gabapentin—epilepsy syndrome	6.87e-05	0.000292	CcSEcCtD
Dolasetron—Diarrhoea—Phenytoin—epilepsy syndrome	6.87e-05	0.000292	CcSEcCtD
Dolasetron—Discomfort—Pregabalin—epilepsy syndrome	6.86e-05	0.000291	CcSEcCtD
Dolasetron—Diarrhoea—Oxcarbazepine—epilepsy syndrome	6.83e-05	0.00029	CcSEcCtD
Dolasetron—Angioedema—Gabapentin—epilepsy syndrome	6.83e-05	0.00029	CcSEcCtD
Dolasetron—Hypersensitivity—Lamotrigine—epilepsy syndrome	6.82e-05	0.00029	CcSEcCtD
Dolasetron—Dry mouth—Pregabalin—epilepsy syndrome	6.79e-05	0.000288	CcSEcCtD
Dolasetron—Pruritus—Carbamazepine—epilepsy syndrome	6.78e-05	0.000288	CcSEcCtD
Dolasetron—Rash—Felbamate—epilepsy syndrome	6.76e-05	0.000287	CcSEcCtD
Dolasetron—Dermatitis—Felbamate—epilepsy syndrome	6.75e-05	0.000287	CcSEcCtD
Dolasetron—Malaise—Gabapentin—epilepsy syndrome	6.74e-05	0.000286	CcSEcCtD
Dolasetron—Tinnitus—Topiramate—epilepsy syndrome	6.74e-05	0.000286	CcSEcCtD
Dolasetron—Vertigo—Gabapentin—epilepsy syndrome	6.72e-05	0.000285	CcSEcCtD
Dolasetron—Headache—Felbamate—epilepsy syndrome	6.71e-05	0.000285	CcSEcCtD
Dolasetron—Confusional state—Pregabalin—epilepsy syndrome	6.71e-05	0.000285	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	6.71e-05	0.000285	CcSEcCtD
Dolasetron—Flushing—Topiramate—epilepsy syndrome	6.71e-05	0.000285	CcSEcCtD
Dolasetron—Syncope—Gabapentin—epilepsy syndrome	6.7e-05	0.000285	CcSEcCtD
Dolasetron—Dizziness—Clonazepam—epilepsy syndrome	6.68e-05	0.000284	CcSEcCtD
Dolasetron—Oedema—Pregabalin—epilepsy syndrome	6.65e-05	0.000282	CcSEcCtD
Dolasetron—Anaphylactic shock—Pregabalin—epilepsy syndrome	6.65e-05	0.000282	CcSEcCtD
Dolasetron—Asthenia—Lamotrigine—epilepsy syndrome	6.64e-05	0.000282	CcSEcCtD
Dolasetron—Dizziness—Phenytoin—epilepsy syndrome	6.64e-05	0.000282	CcSEcCtD
Dolasetron—Rash—Zonisamide—epilepsy syndrome	6.61e-05	0.000281	CcSEcCtD
Dolasetron—Paraesthesia—Valproic Acid—epilepsy syndrome	6.61e-05	0.000281	CcSEcCtD
Dolasetron—Palpitations—Gabapentin—epilepsy syndrome	6.61e-05	0.00028	CcSEcCtD
Dolasetron—Dermatitis—Zonisamide—epilepsy syndrome	6.61e-05	0.00028	CcSEcCtD
Dolasetron—Dizziness—Oxcarbazepine—epilepsy syndrome	6.6e-05	0.00028	CcSEcCtD
Dolasetron—Loss of consciousness—Gabapentin—epilepsy syndrome	6.57e-05	0.000279	CcSEcCtD
Dolasetron—Headache—Zonisamide—epilepsy syndrome	6.57e-05	0.000279	CcSEcCtD
Dolasetron—Dyspnoea—Valproic Acid—epilepsy syndrome	6.56e-05	0.000279	CcSEcCtD
Dolasetron—Diarrhoea—Carbamazepine—epilepsy syndrome	6.56e-05	0.000278	CcSEcCtD
Dolasetron—Pruritus—Lamotrigine—epilepsy syndrome	6.55e-05	0.000278	CcSEcCtD
Dolasetron—Shock—Pregabalin—epilepsy syndrome	6.55e-05	0.000278	CcSEcCtD
Dolasetron—Somnolence—Valproic Acid—epilepsy syndrome	6.54e-05	0.000278	CcSEcCtD
Dolasetron—Cough—Gabapentin—epilepsy syndrome	6.52e-05	0.000277	CcSEcCtD
Dolasetron—HTR3A—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	6.52e-05	0.0015	CbGpPWpGaD
Dolasetron—Thrombocytopenia—Pregabalin—epilepsy syndrome	6.51e-05	0.000277	CcSEcCtD
Dolasetron—Tachycardia—Pregabalin—epilepsy syndrome	6.49e-05	0.000276	CcSEcCtD
Dolasetron—Chills—Topiramate—epilepsy syndrome	6.48e-05	0.000275	CcSEcCtD
Dolasetron—Dyspepsia—Valproic Acid—epilepsy syndrome	6.48e-05	0.000275	CcSEcCtD
Dolasetron—Convulsion—Gabapentin—epilepsy syndrome	6.48e-05	0.000275	CcSEcCtD
Dolasetron—Hypertension—Gabapentin—epilepsy syndrome	6.45e-05	0.000274	CcSEcCtD
Dolasetron—Hyperhidrosis—Pregabalin—epilepsy syndrome	6.43e-05	0.000273	CcSEcCtD
Dolasetron—Decreased appetite—Valproic Acid—epilepsy syndrome	6.4e-05	0.000272	CcSEcCtD
Dolasetron—Rash—Clonazepam—epilepsy syndrome	6.37e-05	0.000271	CcSEcCtD
Dolasetron—Dermatitis—Clonazepam—epilepsy syndrome	6.37e-05	0.00027	CcSEcCtD
Dolasetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—epilepsy syndrome	6.37e-05	0.00146	CbGpPWpGaD
Dolasetron—Arthralgia—Gabapentin—epilepsy syndrome	6.36e-05	0.00027	CcSEcCtD
Dolasetron—Myalgia—Gabapentin—epilepsy syndrome	6.36e-05	0.00027	CcSEcCtD
Dolasetron—Chest pain—Gabapentin—epilepsy syndrome	6.36e-05	0.00027	CcSEcCtD
Dolasetron—Fatigue—Valproic Acid—epilepsy syndrome	6.35e-05	0.000269	CcSEcCtD
Dolasetron—Anxiety—Gabapentin—epilepsy syndrome	6.34e-05	0.000269	CcSEcCtD
Dolasetron—Anorexia—Pregabalin—epilepsy syndrome	6.34e-05	0.000269	CcSEcCtD
Dolasetron—Dizziness—Carbamazepine—epilepsy syndrome	6.34e-05	0.000269	CcSEcCtD
Dolasetron—Diarrhoea—Lamotrigine—epilepsy syndrome	6.34e-05	0.000269	CcSEcCtD
Dolasetron—Headache—Clonazepam—epilepsy syndrome	6.33e-05	0.000269	CcSEcCtD
Dolasetron—Rash—Phenytoin—epilepsy syndrome	6.33e-05	0.000269	CcSEcCtD
Dolasetron—Dermatitis—Phenytoin—epilepsy syndrome	6.32e-05	0.000269	CcSEcCtD
Dolasetron—Rash—Oxcarbazepine—epilepsy syndrome	6.3e-05	0.000267	CcSEcCtD
Dolasetron—Pain—Valproic Acid—epilepsy syndrome	6.29e-05	0.000267	CcSEcCtD
Dolasetron—Constipation—Valproic Acid—epilepsy syndrome	6.29e-05	0.000267	CcSEcCtD
Dolasetron—Dermatitis—Oxcarbazepine—epilepsy syndrome	6.29e-05	0.000267	CcSEcCtD
Dolasetron—Headache—Phenytoin—epilepsy syndrome	6.29e-05	0.000267	CcSEcCtD
Dolasetron—Discomfort—Gabapentin—epilepsy syndrome	6.29e-05	0.000267	CcSEcCtD
Dolasetron—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—epilepsy syndrome	6.28e-05	0.00144	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—VEGFA—epilepsy syndrome	6.27e-05	0.00144	CbGpPWpGaD
Dolasetron—Headache—Oxcarbazepine—epilepsy syndrome	6.26e-05	0.000266	CcSEcCtD
Dolasetron—Dry mouth—Gabapentin—epilepsy syndrome	6.22e-05	0.000264	CcSEcCtD
Dolasetron—Hypotension—Pregabalin—epilepsy syndrome	6.22e-05	0.000264	CcSEcCtD
Dolasetron—HTR3A—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	6.22e-05	0.00143	CbGpPWpGaD
Dolasetron—Flatulence—Topiramate—epilepsy syndrome	6.2e-05	0.000263	CcSEcCtD
Dolasetron—Dysgeusia—Topiramate—epilepsy syndrome	6.16e-05	0.000261	CcSEcCtD
Dolasetron—Confusional state—Gabapentin—epilepsy syndrome	6.15e-05	0.000261	CcSEcCtD
Dolasetron—Dizziness—Lamotrigine—epilepsy syndrome	6.12e-05	0.00026	CcSEcCtD
Dolasetron—Anaphylactic shock—Gabapentin—epilepsy syndrome	6.1e-05	0.000259	CcSEcCtD
Dolasetron—Oedema—Gabapentin—epilepsy syndrome	6.1e-05	0.000259	CcSEcCtD
Dolasetron—Feeling abnormal—Valproic Acid—epilepsy syndrome	6.06e-05	0.000257	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	6.06e-05	0.000257	CcSEcCtD
Dolasetron—Rash—Carbamazepine—epilepsy syndrome	6.04e-05	0.000257	CcSEcCtD
Dolasetron—Dermatitis—Carbamazepine—epilepsy syndrome	6.04e-05	0.000256	CcSEcCtD
Dolasetron—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	6.02e-05	0.000256	CcSEcCtD
Dolasetron—Headache—Carbamazepine—epilepsy syndrome	6e-05	0.000255	CcSEcCtD
Dolasetron—Shock—Gabapentin—epilepsy syndrome	6e-05	0.000255	CcSEcCtD
Dolasetron—Paraesthesia—Pregabalin—epilepsy syndrome	5.97e-05	0.000254	CcSEcCtD
Dolasetron—Thrombocytopenia—Gabapentin—epilepsy syndrome	5.97e-05	0.000254	CcSEcCtD
Dolasetron—Tachycardia—Gabapentin—epilepsy syndrome	5.95e-05	0.000253	CcSEcCtD
Dolasetron—Dyspnoea—Pregabalin—epilepsy syndrome	5.93e-05	0.000252	CcSEcCtD
Dolasetron—Somnolence—Pregabalin—epilepsy syndrome	5.91e-05	0.000251	CcSEcCtD
Dolasetron—Hyperhidrosis—Gabapentin—epilepsy syndrome	5.9e-05	0.00025	CcSEcCtD
Dolasetron—Tremor—Topiramate—epilepsy syndrome	5.89e-05	0.00025	CcSEcCtD
Dolasetron—Urticaria—Valproic Acid—epilepsy syndrome	5.85e-05	0.000248	CcSEcCtD
Dolasetron—Rash—Lamotrigine—epilepsy syndrome	5.84e-05	0.000248	CcSEcCtD
Dolasetron—Ill-defined disorder—Topiramate—epilepsy syndrome	5.84e-05	0.000248	CcSEcCtD
Dolasetron—Dermatitis—Lamotrigine—epilepsy syndrome	5.83e-05	0.000248	CcSEcCtD
Dolasetron—Body temperature increased—Valproic Acid—epilepsy syndrome	5.82e-05	0.000247	CcSEcCtD
Dolasetron—Abdominal pain—Valproic Acid—epilepsy syndrome	5.82e-05	0.000247	CcSEcCtD
Dolasetron—Anorexia—Gabapentin—epilepsy syndrome	5.82e-05	0.000247	CcSEcCtD
Dolasetron—Anaemia—Topiramate—epilepsy syndrome	5.81e-05	0.000247	CcSEcCtD
Dolasetron—Headache—Lamotrigine—epilepsy syndrome	5.8e-05	0.000246	CcSEcCtD
Dolasetron—Decreased appetite—Pregabalin—epilepsy syndrome	5.78e-05	0.000246	CcSEcCtD
Dolasetron—Agitation—Topiramate—epilepsy syndrome	5.78e-05	0.000245	CcSEcCtD
Dolasetron—CYP3A4—Tryptophan metabolism—CAT—epilepsy syndrome	5.78e-05	0.00133	CbGpPWpGaD
Dolasetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C19—epilepsy syndrome	5.75e-05	0.00132	CbGpPWpGaD
Dolasetron—Fatigue—Pregabalin—epilepsy syndrome	5.74e-05	0.000244	CcSEcCtD
Dolasetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	5.72e-05	0.00131	CbGpPWpGaD
Dolasetron—Hypotension—Gabapentin—epilepsy syndrome	5.7e-05	0.000242	CcSEcCtD
Dolasetron—Pain—Pregabalin—epilepsy syndrome	5.69e-05	0.000242	CcSEcCtD
Dolasetron—Constipation—Pregabalin—epilepsy syndrome	5.69e-05	0.000242	CcSEcCtD
Dolasetron—Malaise—Topiramate—epilepsy syndrome	5.67e-05	0.000241	CcSEcCtD
Dolasetron—Vertigo—Topiramate—epilepsy syndrome	5.65e-05	0.00024	CcSEcCtD
Dolasetron—Syncope—Topiramate—epilepsy syndrome	5.64e-05	0.000239	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	5.56e-05	0.000236	CcSEcCtD
Dolasetron—Palpitations—Topiramate—epilepsy syndrome	5.56e-05	0.000236	CcSEcCtD
Dolasetron—Loss of consciousness—Topiramate—epilepsy syndrome	5.53e-05	0.000235	CcSEcCtD
Dolasetron—Cough—Topiramate—epilepsy syndrome	5.49e-05	0.000233	CcSEcCtD
Dolasetron—Feeling abnormal—Pregabalin—epilepsy syndrome	5.48e-05	0.000233	CcSEcCtD
Dolasetron—Paraesthesia—Gabapentin—epilepsy syndrome	5.48e-05	0.000233	CcSEcCtD
Dolasetron—Convulsion—Topiramate—epilepsy syndrome	5.45e-05	0.000231	CcSEcCtD
Dolasetron—Gastrointestinal pain—Pregabalin—epilepsy syndrome	5.44e-05	0.000231	CcSEcCtD
Dolasetron—Dyspnoea—Gabapentin—epilepsy syndrome	5.44e-05	0.000231	CcSEcCtD
Dolasetron—Hypertension—Topiramate—epilepsy syndrome	5.43e-05	0.000231	CcSEcCtD
Dolasetron—Somnolence—Gabapentin—epilepsy syndrome	5.42e-05	0.00023	CcSEcCtD
Dolasetron—Hypersensitivity—Valproic Acid—epilepsy syndrome	5.42e-05	0.00023	CcSEcCtD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—FAR1—epilepsy syndrome	5.39e-05	0.00124	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—CERS1—epilepsy syndrome	5.39e-05	0.00124	CbGpPWpGaD
Dolasetron—Dyspepsia—Gabapentin—epilepsy syndrome	5.37e-05	0.000228	CcSEcCtD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—TNF—epilepsy syndrome	5.37e-05	0.00123	CbGpPWpGaD
Dolasetron—Myalgia—Topiramate—epilepsy syndrome	5.35e-05	0.000227	CcSEcCtD
Dolasetron—Arthralgia—Topiramate—epilepsy syndrome	5.35e-05	0.000227	CcSEcCtD
Dolasetron—Chest pain—Topiramate—epilepsy syndrome	5.35e-05	0.000227	CcSEcCtD
Dolasetron—Anxiety—Topiramate—epilepsy syndrome	5.34e-05	0.000227	CcSEcCtD
Dolasetron—Decreased appetite—Gabapentin—epilepsy syndrome	5.3e-05	0.000225	CcSEcCtD
Dolasetron—Discomfort—Topiramate—epilepsy syndrome	5.29e-05	0.000225	CcSEcCtD
Dolasetron—Urticaria—Pregabalin—epilepsy syndrome	5.29e-05	0.000224	CcSEcCtD
Dolasetron—Asthenia—Valproic Acid—epilepsy syndrome	5.28e-05	0.000224	CcSEcCtD
Dolasetron—Fatigue—Gabapentin—epilepsy syndrome	5.26e-05	0.000223	CcSEcCtD
Dolasetron—Body temperature increased—Pregabalin—epilepsy syndrome	5.26e-05	0.000223	CcSEcCtD
Dolasetron—Abdominal pain—Pregabalin—epilepsy syndrome	5.26e-05	0.000223	CcSEcCtD
Dolasetron—Dry mouth—Topiramate—epilepsy syndrome	5.24e-05	0.000222	CcSEcCtD
Dolasetron—Constipation—Gabapentin—epilepsy syndrome	5.22e-05	0.000222	CcSEcCtD
Dolasetron—Pain—Gabapentin—epilepsy syndrome	5.22e-05	0.000222	CcSEcCtD
Dolasetron—Pruritus—Valproic Acid—epilepsy syndrome	5.21e-05	0.000221	CcSEcCtD
Dolasetron—Confusional state—Topiramate—epilepsy syndrome	5.18e-05	0.00022	CcSEcCtD
Dolasetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	5.16e-05	0.00119	CbGpPWpGaD
Dolasetron—Oedema—Topiramate—epilepsy syndrome	5.13e-05	0.000218	CcSEcCtD
Dolasetron—HTR3A—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	5.11e-05	0.00117	CbGpPWpGaD
Dolasetron—HTR3A—Transmembrane transport of small molecules—AVP—epilepsy syndrome	5.07e-05	0.00116	CbGpPWpGaD
Dolasetron—Shock—Topiramate—epilepsy syndrome	5.05e-05	0.000214	CcSEcCtD
Dolasetron—Diarrhoea—Valproic Acid—epilepsy syndrome	5.04e-05	0.000214	CcSEcCtD
Dolasetron—Feeling abnormal—Gabapentin—epilepsy syndrome	5.03e-05	0.000213	CcSEcCtD
Dolasetron—Thrombocytopenia—Topiramate—epilepsy syndrome	5.03e-05	0.000213	CcSEcCtD
Dolasetron—Tachycardia—Topiramate—epilepsy syndrome	5.01e-05	0.000213	CcSEcCtD
Dolasetron—Gastrointestinal pain—Gabapentin—epilepsy syndrome	4.99e-05	0.000212	CcSEcCtD
Dolasetron—Hyperhidrosis—Topiramate—epilepsy syndrome	4.96e-05	0.000211	CcSEcCtD
Dolasetron—HTR3A—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	4.91e-05	0.00113	CbGpPWpGaD
Dolasetron—Hypersensitivity—Pregabalin—epilepsy syndrome	4.9e-05	0.000208	CcSEcCtD
Dolasetron—Anorexia—Topiramate—epilepsy syndrome	4.89e-05	0.000208	CcSEcCtD
Dolasetron—Dizziness—Valproic Acid—epilepsy syndrome	4.87e-05	0.000207	CcSEcCtD
Dolasetron—Urticaria—Gabapentin—epilepsy syndrome	4.85e-05	0.000206	CcSEcCtD
Dolasetron—Abdominal pain—Gabapentin—epilepsy syndrome	4.82e-05	0.000205	CcSEcCtD
Dolasetron—Body temperature increased—Gabapentin—epilepsy syndrome	4.82e-05	0.000205	CcSEcCtD
Dolasetron—Hypotension—Topiramate—epilepsy syndrome	4.8e-05	0.000204	CcSEcCtD
Dolasetron—Asthenia—Pregabalin—epilepsy syndrome	4.77e-05	0.000203	CcSEcCtD
Dolasetron—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	4.77e-05	0.0011	CbGpPWpGaD
Dolasetron—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	4.73e-05	0.00109	CbGpPWpGaD
Dolasetron—Pruritus—Pregabalin—epilepsy syndrome	4.71e-05	0.0002	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	4.68e-05	0.000199	CcSEcCtD
Dolasetron—CYP2D6—Biological oxidations—CYP2C19—epilepsy syndrome	4.67e-05	0.00107	CbGpPWpGaD
Dolasetron—CYP2D6—Biological oxidations—CYP11A1—epilepsy syndrome	4.65e-05	0.00107	CbGpPWpGaD
Dolasetron—Rash—Valproic Acid—epilepsy syndrome	4.64e-05	0.000197	CcSEcCtD
Dolasetron—Dermatitis—Valproic Acid—epilepsy syndrome	4.64e-05	0.000197	CcSEcCtD
Dolasetron—CYP2C9—Biological oxidations—CYP2C19—epilepsy syndrome	4.63e-05	0.00106	CbGpPWpGaD
Dolasetron—Headache—Valproic Acid—epilepsy syndrome	4.61e-05	0.000196	CcSEcCtD
Dolasetron—CYP2D6—Metapathway biotransformation—CYP2C19—epilepsy syndrome	4.61e-05	0.00106	CbGpPWpGaD
Dolasetron—Paraesthesia—Topiramate—epilepsy syndrome	4.61e-05	0.000196	CcSEcCtD
Dolasetron—CYP2C9—Biological oxidations—CYP11A1—epilepsy syndrome	4.61e-05	0.00106	CbGpPWpGaD
Dolasetron—CYP2D6—Metapathway biotransformation—CYP11A1—epilepsy syndrome	4.58e-05	0.00105	CbGpPWpGaD
Dolasetron—Dyspnoea—Topiramate—epilepsy syndrome	4.58e-05	0.000194	CcSEcCtD
Dolasetron—CYP2C9—Metapathway biotransformation—CYP2C19—epilepsy syndrome	4.57e-05	0.00105	CbGpPWpGaD
Dolasetron—Somnolence—Topiramate—epilepsy syndrome	4.56e-05	0.000194	CcSEcCtD
Dolasetron—Diarrhoea—Pregabalin—epilepsy syndrome	4.55e-05	0.000193	CcSEcCtD
Dolasetron—CYP2C9—Metapathway biotransformation—CYP11A1—epilepsy syndrome	4.54e-05	0.00104	CbGpPWpGaD
Dolasetron—Dyspepsia—Topiramate—epilepsy syndrome	4.52e-05	0.000192	CcSEcCtD
Dolasetron—Hypersensitivity—Gabapentin—epilepsy syndrome	4.49e-05	0.000191	CcSEcCtD
Dolasetron—Decreased appetite—Topiramate—epilepsy syndrome	4.46e-05	0.000189	CcSEcCtD
Dolasetron—Fatigue—Topiramate—epilepsy syndrome	4.43e-05	0.000188	CcSEcCtD
Dolasetron—Dizziness—Pregabalin—epilepsy syndrome	4.4e-05	0.000187	CcSEcCtD
Dolasetron—Pain—Topiramate—epilepsy syndrome	4.39e-05	0.000186	CcSEcCtD
Dolasetron—Constipation—Topiramate—epilepsy syndrome	4.39e-05	0.000186	CcSEcCtD
Dolasetron—Asthenia—Gabapentin—epilepsy syndrome	4.38e-05	0.000186	CcSEcCtD
Dolasetron—CYP2C9—Arachidonic acid metabolism—PTGS2—epilepsy syndrome	4.36e-05	0.001	CbGpPWpGaD
Dolasetron—Pruritus—Gabapentin—epilepsy syndrome	4.32e-05	0.000183	CcSEcCtD
Dolasetron—Feeling abnormal—Topiramate—epilepsy syndrome	4.23e-05	0.00018	CcSEcCtD
Dolasetron—Gastrointestinal pain—Topiramate—epilepsy syndrome	4.2e-05	0.000178	CcSEcCtD
Dolasetron—Rash—Pregabalin—epilepsy syndrome	4.2e-05	0.000178	CcSEcCtD
Dolasetron—Dermatitis—Pregabalin—epilepsy syndrome	4.19e-05	0.000178	CcSEcCtD
Dolasetron—Diarrhoea—Gabapentin—epilepsy syndrome	4.17e-05	0.000177	CcSEcCtD
Dolasetron—Headache—Pregabalin—epilepsy syndrome	4.17e-05	0.000177	CcSEcCtD
Dolasetron—CYP2C9—Biological oxidations—CYP2D6—epilepsy syndrome	4.16e-05	0.000955	CbGpPWpGaD
Dolasetron—CYP2C9—Metapathway biotransformation—CYP2D6—epilepsy syndrome	4.1e-05	0.000942	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	4.09e-05	0.000939	CbGpPWpGaD
Dolasetron—Urticaria—Topiramate—epilepsy syndrome	4.08e-05	0.000173	CcSEcCtD
Dolasetron—Abdominal pain—Topiramate—epilepsy syndrome	4.06e-05	0.000172	CcSEcCtD
Dolasetron—Body temperature increased—Topiramate—epilepsy syndrome	4.06e-05	0.000172	CcSEcCtD
Dolasetron—Dizziness—Gabapentin—epilepsy syndrome	4.03e-05	0.000171	CcSEcCtD
Dolasetron—CYP2D6—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	3.87e-05	0.000888	CbGpPWpGaD
Dolasetron—Rash—Gabapentin—epilepsy syndrome	3.85e-05	0.000163	CcSEcCtD
Dolasetron—Dermatitis—Gabapentin—epilepsy syndrome	3.84e-05	0.000163	CcSEcCtD
Dolasetron—CYP2C9—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	3.83e-05	0.000881	CbGpPWpGaD
Dolasetron—Headache—Gabapentin—epilepsy syndrome	3.82e-05	0.000162	CcSEcCtD
Dolasetron—Hypersensitivity—Topiramate—epilepsy syndrome	3.78e-05	0.000161	CcSEcCtD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	3.74e-05	0.000859	CbGpPWpGaD
Dolasetron—Asthenia—Topiramate—epilepsy syndrome	3.68e-05	0.000156	CcSEcCtD
Dolasetron—Pruritus—Topiramate—epilepsy syndrome	3.63e-05	0.000154	CcSEcCtD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	3.6e-05	0.000827	CbGpPWpGaD
Dolasetron—Diarrhoea—Topiramate—epilepsy syndrome	3.51e-05	0.000149	CcSEcCtD
Dolasetron—Dizziness—Topiramate—epilepsy syndrome	3.39e-05	0.000144	CcSEcCtD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	3.27e-05	0.000751	CbGpPWpGaD
Dolasetron—Rash—Topiramate—epilepsy syndrome	3.24e-05	0.000137	CcSEcCtD
Dolasetron—Dermatitis—Topiramate—epilepsy syndrome	3.23e-05	0.000137	CcSEcCtD
Dolasetron—Headache—Topiramate—epilepsy syndrome	3.22e-05	0.000137	CcSEcCtD
Dolasetron—CYP2D6—Metabolism—CA13—epilepsy syndrome	3.2e-05	0.000735	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CA13—epilepsy syndrome	3.17e-05	0.000728	CbGpPWpGaD
Dolasetron—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	3.12e-05	0.000716	CbGpPWpGaD
Dolasetron—HTR3A—Transmembrane transport of small molecules—ALB—epilepsy syndrome	3.07e-05	0.000705	CbGpPWpGaD
Dolasetron—CYP3A4—Biological oxidations—CYP2C19—epilepsy syndrome	3.06e-05	0.000702	CbGpPWpGaD
Dolasetron—CYP3A4—Biological oxidations—CYP11A1—epilepsy syndrome	3.04e-05	0.000698	CbGpPWpGaD
Dolasetron—CYP3A4—Metapathway biotransformation—CYP2C19—epilepsy syndrome	3.01e-05	0.000692	CbGpPWpGaD
Dolasetron—CYP3A4—Metapathway biotransformation—CYP11A1—epilepsy syndrome	3e-05	0.000688	CbGpPWpGaD
Dolasetron—CYP3A4—Biological oxidations—CYP2D6—epilepsy syndrome	2.74e-05	0.00063	CbGpPWpGaD
Dolasetron—CYP3A4—Metapathway biotransformation—CYP2D6—epilepsy syndrome	2.7e-05	0.000621	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	2.55e-05	0.000586	CbGpPWpGaD
Dolasetron—CYP3A4—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	2.53e-05	0.000581	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—FAR1—epilepsy syndrome	2.42e-05	0.000557	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—GLUD1—epilepsy syndrome	2.42e-05	0.000557	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—L2HGDH—epilepsy syndrome	2.42e-05	0.000557	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PDXK—epilepsy syndrome	2.42e-05	0.000557	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CERS1—epilepsy syndrome	2.42e-05	0.000557	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ADK—epilepsy syndrome	2.42e-05	0.000557	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—FAR1—epilepsy syndrome	2.4e-05	0.000552	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—L2HGDH—epilepsy syndrome	2.4e-05	0.000552	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CERS1—epilepsy syndrome	2.4e-05	0.000552	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ADK—epilepsy syndrome	2.4e-05	0.000552	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—GLUD1—epilepsy syndrome	2.4e-05	0.000552	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PDXK—epilepsy syndrome	2.4e-05	0.000552	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PNPO—epilepsy syndrome	2.22e-05	0.000509	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—NHLRC1—epilepsy syndrome	2.22e-05	0.000509	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—GAMT—epilepsy syndrome	2.22e-05	0.000509	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—EPM2A—epilepsy syndrome	2.22e-05	0.000509	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—NHLRC1—epilepsy syndrome	2.2e-05	0.000505	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—GAMT—epilepsy syndrome	2.2e-05	0.000505	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—EPM2A—epilepsy syndrome	2.2e-05	0.000505	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PNPO—epilepsy syndrome	2.2e-05	0.000505	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CA13—epilepsy syndrome	2.09e-05	0.00048	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CA4—epilepsy syndrome	2.06e-05	0.000473	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—QDPR—epilepsy syndrome	2.06e-05	0.000473	CbGpPWpGaD
Dolasetron—CYP2D6—Biological oxidations—POMC—epilepsy syndrome	2.05e-05	0.000472	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CA4—epilepsy syndrome	2.04e-05	0.000469	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—QDPR—epilepsy syndrome	2.04e-05	0.000469	CbGpPWpGaD
Dolasetron—CYP2C9—Biological oxidations—POMC—epilepsy syndrome	2.04e-05	0.000468	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—COX3—epilepsy syndrome	1.94e-05	0.000445	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—COX3—epilepsy syndrome	1.92e-05	0.000441	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CACNA2D2—epilepsy syndrome	1.84e-05	0.000422	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PFKL—epilepsy syndrome	1.84e-05	0.000422	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—SLCO1A2—epilepsy syndrome	1.84e-05	0.000422	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—KCNB1—epilepsy syndrome	1.84e-05	0.000422	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—SLC6A8—epilepsy syndrome	1.84e-05	0.000422	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CACNA2D2—epilepsy syndrome	1.82e-05	0.000418	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—SLCO1A2—epilepsy syndrome	1.82e-05	0.000418	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PFKL—epilepsy syndrome	1.82e-05	0.000418	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—KCNB1—epilepsy syndrome	1.82e-05	0.000418	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—SLC6A8—epilepsy syndrome	1.82e-05	0.000418	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	1.78e-05	0.000409	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	1.77e-05	0.000406	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ATIC—epilepsy syndrome	1.68e-05	0.000386	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—UPB1—epilepsy syndrome	1.68e-05	0.000386	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—NEU1—epilepsy syndrome	1.68e-05	0.000386	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—UPB1—epilepsy syndrome	1.67e-05	0.000383	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—NEU1—epilepsy syndrome	1.67e-05	0.000383	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ATIC—epilepsy syndrome	1.67e-05	0.000383	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—HSD17B4—epilepsy syndrome	1.62e-05	0.000371	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—HSD17B4—epilepsy syndrome	1.6e-05	0.000368	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PDXK—epilepsy syndrome	1.58e-05	0.000364	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	1.58e-05	0.000364	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CERS1—epilepsy syndrome	1.58e-05	0.000364	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	1.58e-05	0.000364	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ADK—epilepsy syndrome	1.58e-05	0.000364	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—FAR1—epilepsy syndrome	1.58e-05	0.000364	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PPP1R3C—epilepsy syndrome	1.56e-05	0.000359	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—GBE1—epilepsy syndrome	1.56e-05	0.000359	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PPP1R3C—epilepsy syndrome	1.55e-05	0.000356	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—GBE1—epilepsy syndrome	1.55e-05	0.000356	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.51e-05	0.000348	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ASAH1—epilepsy syndrome	1.47e-05	0.000337	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ASAH1—epilepsy syndrome	1.46e-05	0.000334	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—GAMT—epilepsy syndrome	1.45e-05	0.000333	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PNPO—epilepsy syndrome	1.45e-05	0.000333	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	1.45e-05	0.000333	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	1.45e-05	0.000333	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—STXBP1—epilepsy syndrome	1.43e-05	0.000328	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—STXBP1—epilepsy syndrome	1.42e-05	0.000325	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ALAD—epilepsy syndrome	1.39e-05	0.00032	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—NT5E—epilepsy syndrome	1.39e-05	0.00032	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—NT5E—epilepsy syndrome	1.38e-05	0.000317	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ALAD—epilepsy syndrome	1.38e-05	0.000317	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CA4—epilepsy syndrome	1.35e-05	0.000309	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—QDPR—epilepsy syndrome	1.35e-05	0.000309	CbGpPWpGaD
Dolasetron—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	1.34e-05	0.000309	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ALDH7A1—epilepsy syndrome	1.33e-05	0.000305	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CACNA1A—epilepsy syndrome	1.33e-05	0.000305	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CACNA1A—epilepsy syndrome	1.32e-05	0.000302	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ALDH7A1—epilepsy syndrome	1.32e-05	0.000302	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ST3GAL3—epilepsy syndrome	1.3e-05	0.000299	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	1.29e-05	0.000296	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ADSL—epilepsy syndrome	1.27e-05	0.000292	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—COX3—epilepsy syndrome	1.27e-05	0.000291	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ADSL—epilepsy syndrome	1.26e-05	0.00029	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—GLUL—epilepsy syndrome	1.25e-05	0.000287	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—GLUL—epilepsy syndrome	1.24e-05	0.000284	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	1.23e-05	0.000282	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	1.21e-05	0.000279	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	1.2e-05	0.000276	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	1.2e-05	0.000276	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	1.2e-05	0.000276	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PFKL—epilepsy syndrome	1.2e-05	0.000276	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	1.2e-05	0.000276	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	1.15e-05	0.000263	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	1.14e-05	0.000261	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—AQP1—epilepsy syndrome	1.11e-05	0.000256	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—AQP1—epilepsy syndrome	1.1e-05	0.000253	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ATIC—epilepsy syndrome	1.1e-05	0.000252	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—UPB1—epilepsy syndrome	1.1e-05	0.000252	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—NEU1—epilepsy syndrome	1.1e-05	0.000252	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.06e-05	0.000243	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	1.06e-05	0.000243	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	1.02e-05	0.000235	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—GBE1—epilepsy syndrome	1.02e-05	0.000235	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	1.01e-05	0.000231	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	1.01e-05	0.000231	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	9.98e-06	0.000229	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	9.98e-06	0.000229	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	9.6e-06	0.000221	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	9.34e-06	0.000215	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	9.29e-06	0.000213	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	9.1e-06	0.000209	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—NT5E—epilepsy syndrome	9.1e-06	0.000209	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ALAD—epilepsy syndrome	9.1e-06	0.000209	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	8.68e-06	0.000199	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	8.68e-06	0.000199	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	8.5e-06	0.000195	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ADSL—epilepsy syndrome	8.32e-06	0.000191	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	8.2e-06	0.000188	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—GLUL—epilepsy syndrome	8.16e-06	0.000188	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	8.13e-06	0.000187	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	8.01e-06	0.000184	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	7.99e-06	0.000184	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	7.94e-06	0.000183	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	7.92e-06	0.000182	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	7.88e-06	0.000181	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	7.82e-06	0.00018	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	7.49e-06	0.000172	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—AQP1—epilepsy syndrome	7.27e-06	0.000167	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	7.13e-06	0.000164	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	7.11e-06	0.000163	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	6.83e-06	0.000157	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—BCHE—epilepsy syndrome	6.8e-06	0.000156	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	6.77e-06	0.000155	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—BCHE—epilepsy syndrome	6.74e-06	0.000155	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	6.58e-06	0.000151	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	6.58e-06	0.000151	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	6.48e-06	0.000149	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	6.43e-06	0.000148	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	6.41e-06	0.000147	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—TH—epilepsy syndrome	6.39e-06	0.000147	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	6.36e-06	0.000146	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—TH—epilepsy syndrome	6.34e-06	0.000146	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	6.24e-06	0.000143	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	5.36e-06	0.000123	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	5.33e-06	0.000123	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	5.29e-06	0.000121	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CAT—epilepsy syndrome	5.26e-06	0.000121	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	5.23e-06	0.00012	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CAT—epilepsy syndrome	5.22e-06	0.00012	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	5.19e-06	0.000119	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	5.12e-06	0.000118	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	5.08e-06	0.000117	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—GPX1—epilepsy syndrome	4.76e-06	0.000109	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—GPX1—epilepsy syndrome	4.72e-06	0.000108	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	4.69e-06	0.000108	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	4.46e-06	0.000103	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—BCHE—epilepsy syndrome	4.44e-06	0.000102	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	4.24e-06	9.74e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	4.19e-06	9.63e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—TH—epilepsy syndrome	4.18e-06	9.6e-05	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—AGT—epilepsy syndrome	4.17e-06	9.59e-05	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—AGT—epilepsy syndrome	4.14e-06	9.5e-05	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—APOE—epilepsy syndrome	4.09e-06	9.39e-05	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—APOE—epilepsy syndrome	4.05e-06	9.31e-05	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—POMC—epilepsy syndrome	3.51e-06	8.07e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	3.49e-06	8.01e-05	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—POMC—epilepsy syndrome	3.48e-06	8e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CAT—epilepsy syndrome	3.44e-06	7.9e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	3.35e-06	7.69e-05	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ALB—epilepsy syndrome	3.2e-06	7.36e-05	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ALB—epilepsy syndrome	3.17e-06	7.29e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—GPX1—epilepsy syndrome	3.11e-06	7.15e-05	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	2.8e-06	6.44e-05	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	2.78e-06	6.38e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—AGT—epilepsy syndrome	2.73e-06	6.27e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—APOE—epilepsy syndrome	2.67e-06	6.14e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—POMC—epilepsy syndrome	2.3e-06	5.28e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ALB—epilepsy syndrome	2.09e-06	4.81e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	1.83e-06	4.21e-05	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—AKT1—epilepsy syndrome	1.41e-06	3.24e-05	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—AKT1—epilepsy syndrome	1.4e-06	3.21e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—AKT1—epilepsy syndrome	9.21e-07	2.12e-05	CbGpPWpGaD
